Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Sevuparin sodium by Modus Therapeutics for Endotoxemia: Likelihood of Approval
Sevuparin sodium is under clinical development by Modus Therapeutics and currently in Phase I for Endotoxemia. According to GlobalData, Phase...